Search clinical trials for: Otelixizumab

Total 8 results

GlaxoSmithKline

Terminated

Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

France, Germany
GlaxoSmithKline

Terminated

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

Arthritis, Rheumatoid

Russian Federation, Spain, United Kingdom
GlaxoSmithKline
Juvenile Diabetes Research Foundation

Terminated

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) (TTEDD)

Diabetes Mellitus, Type 1

United States, Canada
GlaxoSmithKline

Completed

Subcutaneous Administration of Otelixizumab to T1DM Patients (RAO112438)

Diabetes Mellitus, Type 1

Belgium
GlaxoSmithKline

Terminated

A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease

Graves Ophthalmopathy

United Kingdom
GlaxoSmithKline
Parexel

Completed

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Diabetes Mellitus, Type 1

Belgium
GlaxoSmithKline
Juvenile Diabetes Research Foundation

Completed

Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2 (DEFEND-2)

Diabetes Mellitus, Type 1

Italy
GlaxoSmithKline
Juvenile Diabetes Research Foundation

Completed

Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 (DEFEND-1)

Diabetes Mellitus, Type 1

United States, Finland, Sweden, Italy, Spain, United Kingdom, Germany, Canada, Denmark

3

Subscribe